Global Immunotherapy Drugs Market to Reach $498.4 Billion by 2030
The global market for Immunotherapy Drugs estimated at US$238.4 Billion in the year 2022, is projected to reach a revised size of US$498.4 Billion by 2030, growing at a CAGR of 9.7% over the analysis period 2022-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is projected to record 9.7% CAGR and reach US$229.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Checkpoint Inhibitors segment is readjusted to a revised 10.1% CAGR for the next 8-year period.The U.S. Market is Estimated at $72.7 Billion, While China is Forecast to Grow at 9% CAGR
The Immunotherapy Drugs market in the U.S. is estimated at US$72.7 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$84.9 Billion by the year 2030 trailing a CAGR of 9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.9% and 7.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.8% CAGR.Select Competitors (Total 44 Featured) -
- AbbVie, Inc.
- Amgen, Inc.
- AstraZeneca PLC
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- GlaxoSmithKline PLC
- Johnson & Johnson
- Merck & Co., Inc.
- Novartis International AG
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISCANADAITALYREST OF EUROPEREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie, Inc.
- Amgen, Inc.
- AstraZeneca PLC
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- GlaxoSmithKline PLC
- Johnson & Johnson
- Merck & Co., Inc.
- Novartis International AG
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 193 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 238.4 Billion |
Forecasted Market Value ( USD | $ 498.4 Billion |
Compound Annual Growth Rate | 9.7% |
Regions Covered | Global |